Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma

Clinical trial NCT02391662 · COMPLETED

Trial details

NCT number: NCT02391662
Sponsor: Asociación de Oncología Médica del Hospital de Cruces
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Carcinoma Metastatic

Start date: 2015-06-23
Primary completion: 2019-03-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.